Dynacure

OverviewSuggest Edit

Dynacure is a biotechnology company developing new treatments for patients affected by serious orphan disorders. The Company program is focused on Centronuclear Myopathies (CNM), a debilitating disease affecting children and young adults. It is based on the modulation of the expression of the Dynamin 2 protein, through the use of an antisense oligonucleotide developed in collaboration with Ionis Pharmaceuticals.
TypePrivate
Founded2016
HQIllkirch-Graffenstaden, FR
Websitedynacure.com

Latest Updates

Employees (est.) (Oct 2020)21
Cybersecurity ratingAMore

Key People/Management at Dynacure

Stéphane van Rooijen

Stéphane van Rooijen

CEO, Board Member
Benoit Barteau

Benoit Barteau

Board Member
Frédéric Legros

Frédéric Legros

COO
Frédéric Chereau

Frédéric Chereau

Board Member
Chris Freitag

Chris Freitag

CMO
Rémi Droller

Rémi Droller

Board Member
Show more

Dynacure Office Locations

Dynacure has an office in Illkirch-Graffenstaden
Illkirch-Graffenstaden, FR (HQ)
850 Bd Sébastien Brant
Show all (1)

Dynacure Financials and Metrics

Summary Metrics

Founding Date

2016

Dynacure total Funding

$113.5 m

Dynacure latest funding size

$54.82 m

Time since last funding

7 months ago

Dynacure investors

Dynacure's latest funding round in April 2020 was reported to be $54.8 m. In total, Dynacure has raised $113.5 m
Show all financial metrics

Dynacure Cybersecurity Score

Cybersecurity ratingPremium dataset

A

93/100

SecurityScorecard logo

Dynacure Online and Social Media Presence

Embed Graph

Dynacure News and Updates

Dynacure Announces New Program, DYN201, for Hereditary Spastic Paraplegia (HSP), a Rare Neurodegenerative Disease

STRASBOURG, France and PHILADELPHIA, Oct. 13, 2020 /PRNewswire/ -- Dynacure, a clinical-stage drug development company focused on improving the lives of patients with rare and orphan disorders, announced today that they have entered into a license agreement with the Paris Brain Institute...

Dynacure Announces €50M ($55M) Series C Financing

STRASBOURG, France and PHILADELPHIA, April 2, 2020 /PRNewswire/ -- Dynacure, a clinical stage drug development company focused on improving the lives of patients with rare and orphan disorders, announced today the close of a €50 million Series C financing led by Perceptive Advisors. New...

Dynacure Announces First Patient Dosed in Phase 1 / 2 'UNITE-CNM' Study of DYN101 for the Treatment of Myotubular and Centronuclear Myopathies (CNM)

STRASBOURG, France and PHILADELPHIA, March 5, 2020 /PRNewswire/ -- Dynacure, a clinical stage drug development company focused on improving the lives of patients with rare and orphan disorders, today announced that the first patient has been dosed with DYN101 in a Phase 1 / 2 study called...

Dynacure Presents New Preclinical Results on Muscle Targeting with Antisense Oligonucleotides at the 24th Annual International Congress of the World Muscle Society

STRASBOURG, France, Oct. 2, 2019 /PRNewswire/ -- Dynacure, a clinical stage drug development company focused on improving the lives of patients with rare and orphan disorders, today announced two poster presentations at the 24th Annual International Congress of the World Muscle Society...

Dynacure Announces Approval of Clinical Trial Application for DYN101, an Antisense Medicine to Treat Rare Disease 'Centronuclear Myopathies'

STRASBOURG, France, April 30, 2019 /PRNewswire/ -- Dynacure, a clinical stage drug development company focused on improving the lives of patients with rare and orphan disorders, today announced that The Medicines and Healthcare products Regulatory Agency (MHRA) has approved the Clinical...

Dynacure Frequently Asked Questions

  • When was Dynacure founded?

    Dynacure was founded in 2016.

  • Who are Dynacure key executives?

    Dynacure's key executives are Stéphane van Rooijen, Benoit Barteau and Frédéric Legros.

  • How many employees does Dynacure have?

    Dynacure has 21 employees.

  • Who are Dynacure competitors?

    Competitors of Dynacure include Biogen, Athersys and Vertex Pharmaceuticals.

  • Where is Dynacure headquarters?

    Dynacure headquarters is located at 850 Bd Sébastien Brant, Illkirch-Graffenstaden.

  • Where are Dynacure offices?

    Dynacure has an office in Illkirch-Graffenstaden.

  • How many offices does Dynacure have?

    Dynacure has 1 office.